No Detail Found!

Scrutiny of immunological components (CD20, CD30, and CD40) and HCMV and  EBV infections in lymphoma Iraqi patients

Author(s)
Ahmed Talib Ghadhban College of Dentistry, Al- Muthanna University, Al- Muthanna , Iraq
Marwa Mohammed Ali Jassim College of Dentistry, Al- Muthanna University, Al- Muthanna , Iraq
Majid Mohammed Mahmood Department of Biology, College of Science,Mustansiriyah University,Baghdad , Iraq
Hayder Saad Hanfoosh Al Atabi College of Dentistry, Al- Muthanna University, Al-Muthanna , Iraq
Sameem Atia Rekan Pediatric and gynecology hospital Al Muthana Health Directorate , Iraq
Abstract
Background: This investigation concentrated on Hodgkin and non-Hodgkin lymphomas in the Iraqi province of Al-Muthanna. Environmental and immune characteristics have a role in this malignancy. In an attempt to assess Hodgkin and non-Hodgkin lymphomas in Iraqi patients, in addition to the detection of specific immunological and virological data, 30 patients and 10 controls were scrutinized. Methods: Forty subjects with an age range of 20-82 years, 30 with lymphomas (Hodgkin and non-Hodgkin), and 10 with no lymphomas were analyzed. The tissue blocks were tested for EBER-EBV and PP65-CMV viruses using the in-situ hybridization (ISH) technique with the aid of kits of specific probes for viruses. Also, immunological markers such as CD markers were investigated using immunohistochemistry (IHC). Results: In the Iraqi Al-Muthanna governorate Lymphoma cases rose notably among people beyond sixty. Hodgkin lymphoma cases were found more often than non-Hodgkin lymphoma cases, with a predominance of females in both types. The results of HCMV and EBV detection illustrated a higher prevalence of these viruses, especially in patients with non-Hodgkin lymphoma, accompanied by related immunological changes in lymphoma patients than in the lymphoma-free group. Conclusions: In Al-Muthanna province, Hodgkin and non-Hodgkin lymphomas were slightly increased in females, along with more prevalent HCMV and EBV infections
Publication Details
Page(s) 61-65
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 11, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Human cytomegalovirus, HL-NHL lymphoma, Epstein Barr virus
References
Huang J,Pang WS,Lok V,Zhang L,Lucero-Prisno III DE XuW .2022 .Association of Pacific Rim Universities (APRU). Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. Journal of Hematology & Oncology, 15(1) : 57.
Smith CM,Friedman DL .2022 .Advances in Hodgkin Lymphoma: Including the Patient's Voice. , : 855725.
Stephens DM,Li H,Schöder H,Straus DJ,Moskowitz CH,LeBlanc M,JW Friedberg .2019 .Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. The Journal of the American Society of Hematology, 134(15) : 1238-1246.
Mauz-Körholz C,Landman-Parker J,Balwierz W,Ammann RA,Anderson RA .2022 .Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. The lancet oncology, 23(1) : 125-137.
Burkitt Endemic .2020 .-an aggressive childhood cancer linked to Plasmodium falciparum exposure, but not to exposure to other malaria parasites. Apmis, 128(2) : 129-135.
.2018 .Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial. The Lancet Oncology, 19(9) : 1229-1238.
Broccoli A,Argnani L,Botto B,Corradini P,Pinto A .2019 .Re A. First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi. Blood Cancer Journal, 9(12) : 100.
Society A C. .2020 .American Cancer Society. Cancer Facts & Figures 2020. Am Cancer Soc, : 1-52.
Flerlage JE,Metzger ML,Bhakta N. .2018 .The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice? Blood. The Journal of the American Society of Hematology, 132(4) : 376-384.
Derebas J,Panuciak K,Margas M,Zawitkowska J,Lejman M. .2022 .The new treatment methods for non-hodgkin lymphoma in pediatric patients. Cancers, 14(6) : 1569.
Jassim MM,Naji SA,Mahmood MM .2022 .BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancer. Research Journal of Pharmacy and Technology, 15(9) : 4083-4087.
Jacobsen E. .2022 .Follicular lymphoma:2023 update on diagnosis and management. American Journal of Hematology, 97(12) : 1638-1651.
Chin L,Wong CY,Gill H.,Targeting H. .2023 .Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation. International Journal of Molecular Sciences, 24(4) : 3161.
Amhaz G,Bazarbachi A,El-Cheikh J .2022 .Immunotherapy in indolent Non-Hodgkin's Lymphoma. , 17 : 100325.
Case Clinical,Reports Clinical .2023 .. , 11(2) : 6977.
Flegel K. Burkitt .2023 .'s Lymphoma: The Discovery and Diagnosis of a New Illness. Canadian Journal of General Internal Medicine, 18(1) : 1-8.
Ricard F,Cheson B,Barrington S,Trotman J,Schmid A,Brueggenwerth G .2023 .Korn R. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical). Journal of Nuclear Medicine, 64(1) : 102-108.
Zhao X,Ma Y,Bian H . .CD20 expression is closely associated with Epstein-Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma. , : .
Frontiers in Oncology .2022 .. , : 4717.
Vaccher E,Gloghini A,Volpi C C .2022 .Carbone A. Lymphomas in People Living with HIV. , 3(3) : 527-542.
: Mundo L,Del Porro L,Granai M,Siciliano M C,Mancini V .2020 .Frequent traces of EBV infection in Hodgkin and nonHodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas. Modern Pathology, 33(12) : 2407-2421.
Li D,Oda K,Mikata A .1995 .Yumoto N. Epstein‐Barr virus genomes in Hodgkin's disease and non-Hodgkin's lymphomas. , 45(10) : 735-741.
.2019 .Interplay between EBERS and P27 tumor suppressor proteins in molecular transformation of nasopharyngeal and sinonasal carcinomas. Indian Journal of Public Health, 10(6) : 19.
Sato K,Igarashi S,Tsukada N,Inamura J,Yamamoto M .2022 .Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation. BMC cancer, 22(1) : 944.
Mehravaran H,Makvandi M,Zade AS,Neisi N,Kiani H .2017 .Association of human cytomegalovirus with Hodgkin's disease and non-Hodgkin's lymphomas. Asian Pacific Journal of Cancer Prevention, 18(3) : 593.
Dialysis Nephrology,Transplantation Nephrology .2011 .. , 26(6) : 1769-1775.
Cai ZZ,Xu JG,Zhou YH,Zheng JH,Lin KZ .2016 .Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer. World Journal of Gastroenterology, 22(9) : 2789.
Libard S,Popova SN,Amini RM,Kärjä V,Pietiläinen T,Hämäläinen KM,Alafuzoff I. .2014 .; 9(9): e108861.. PloS one, : .
.2014 .Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 20(6) : 885-890.
Economides MP,Mahale P,Turturro F,Hosry J,Samaniego F .2017 .Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leukemia & Lymphoma, 58(2) : 485-488.
0

Citations

0

Downloads

23

Views